RETA
Reata Pharmaceuticals Inc
Director Shamim Ruff sold $481K of Reata Pharmaceuticals Inc
Sold$480,610
$83.73Price
5,740Shares
−52%Stake
What RETA did after the filing
- The stock from Mon, Mar 13 close, $84.81
- +17.6%
- S&P 500, same days
- +5.8%
Measured over 30 trading days, to the Apr 25 close.
Traded Fri, Mar 10. Filed Mon, Mar 13, 1:23 PM ET, during the session. Returns use the Mar 13 close and the Apr 25 close. Not investment advice.